Veradigm (MDRX) Competitors

Veradigm (NASDAQ:MDRX) and Omnicell (NASDAQ:OMCL) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, media sentiment, valuation, community ranking, earnings and analyst recommendations.

Do insiders & institutionals believe in MDRX or OMCL?

97.7% of Omnicell shares are held by institutional investors. 2.3% of Veradigm shares are held by insiders. Comparatively, 2.5% of Omnicell shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Do analysts prefer MDRX or OMCL?

Veradigm currently has a consensus price target of $14.00, indicating a potential upside of 218.18%. Omnicell has a consensus price target of $50.67, indicating a potential upside of 62.60%. Given Veradigm's stronger consensus rating and higher probable upside, research analysts plainly believe Veradigm is more favorable than Omnicell.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Veradigm	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Omnicell	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Does the media prefer MDRX or OMCL?

In the previous week, Omnicell had 5 more articles in the media than Veradigm. MarketBeat recorded 8 mentions for Omnicell and 3 mentions for Veradigm. Omnicell's average media sentiment score of 1.06 beat Veradigm's score of 0.52 indicating that Omnicell is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Veradigm	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Omnicell	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is MDRX or OMCL more profitable?

Omnicell has a net margin of 1.13% compared to Veradigm's net margin of 0.00%. Omnicell's return on equity of 3.82% beat Veradigm's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Veradigm	N/A	N/A	N/A
Omnicell	1.13%	3.82%	2.07%

Which has stronger valuation and earnings, MDRX or OMCL?

Omnicell has lower revenue, but higher earnings than Veradigm.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Veradigm	$1.53B	0.31	N/A	N/A	N/A
Omnicell	$1.11B	1.31	$12.53M	$0.27	115.41

Does the MarketBeat Community believe in MDRX or OMCL?

Veradigm received 126 more outperform votes than Omnicell when rated by MarketBeat users. However, 66.80% of users gave Omnicell an outperform vote while only 57.71% of users gave Veradigm an outperform vote.

Company	Underperform	Outperform
Veradigm	Outperform Votes 629 57.71%	Underperform Votes 461 42.29%
Omnicell	Outperform Votes 503 66.80%	Underperform Votes 250 33.20%

Which has more volatility and risk, MDRX or OMCL?

Veradigm has a beta of 0.63, meaning that its share price is 37% less volatile than the S&P 500. Comparatively, Omnicell has a beta of 0.78, meaning that its share price is 22% less volatile than the S&P 500.

Summary

Omnicell beats Veradigm on 11 of the 15 factors compared between the two stocks.